Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
Salaam-Dreyer Z, Streicher EM, Sirgel FA, Menardo F, Borrell S, Reinhard M, Doetsch A, Cudahy PGT, Mohr-Holland E, Daniels J, Dippenaar A, Nicol MP, Gagneux S, Warren RM, Cox H. Salaam-Dreyer Z, et al. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0036421. doi: 10.1128/AAC.00364-21. Epub 2021 Aug 30. Antimicrob Agents Chemother. 2021. PMID: 34460307 Free PMC article.
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
Cox H, Salaam-Dreyer Z, Goig GA, Nicol MP, Menardo F, Dippenaar A, Mohr-Holland E, Daniels J, Cudahy PGT, Borrell S, Reinhard M, Doetsch A, Beisel C, Reuter A, Furin J, Gagneux S, Warren RM. Cox H, et al. Among authors: mohr holland e. Lancet Microbe. 2021 Nov;2(11):e584-e593. doi: 10.1016/S2666-5247(21)00144-0. Lancet Microbe. 2021. PMID: 34766068 Free PMC article.
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
Cox H, Goig GA, Salaam-Dreyer Z, Dippenaar A, Reuter A, Mohr-Holland E, Daniels J, Cudahy PGT, Nicol MP, Borrell S, Reinhard M, Doetsch A, Beisel C, Gagneux S, Warren RM, Furin J. Cox H, et al. Among authors: mohr holland e. J Clin Microbiol. 2022 Mar 16;60(3):e0236221. doi: 10.1128/jcm.02362-21. Epub 2022 Mar 16. J Clin Microbiol. 2022. PMID: 35170980 Free PMC article.
Early mortality during rifampicin-resistant TB treatment.
Mohr-Holland E, Daniels J, Reuter A, Rodriguez CA, Mitnick C, Kock Y, Cox V, Furin J, Cox H. Mohr-Holland E, et al. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):150-157. doi: 10.5588/ijtld.21.0494. Int J Tuberc Lung Dis. 2022. PMID: 35086627 Free PMC article.
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19.
Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, Furin J, Pfaff C, Reuter A. Mohr-Holland E, et al. Int J Tuberc Lung Dis. 2021 Sep 1;25(9):772-775. doi: 10.5588/ijtld.21.0340. Int J Tuberc Lung Dis. 2021. PMID: 34802503 Free PMC article. No abstract available.
Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa.
Reuter A, Beko B, Memani B, Furin J, Daniels J, Rodriguez E, Reuter H, Weich L, Isaakidis P, von der Heyden E, Kock Y, Mohr-Holland E. Reuter A, et al. Among authors: mohr holland e. Trop Med Infect Dis. 2022 Jan 31;7(2):21. doi: 10.3390/tropicalmed7020021. Trop Med Infect Dis. 2022. PMID: 35202216 Free PMC article.
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients.
Mohr-Holland E, Daniels J, Douglas-Jones B, Mema N, Scott V, Trivino-Duran L, Pfaff C, Furin J, Isaakidis P. Mohr-Holland E, et al. Int J Tuberc Lung Dis. 2021 May 1;25(5):409-412. doi: 10.5588/ijtld.21.0010. Int J Tuberc Lung Dis. 2021. PMID: 33977912 Free PMC article. No abstract available.
19 results